8/9/2019 PV and Glossary.
1/28
Pharmaco-vigilance
Nidhi
8/9/2019 PV and Glossary.
2/28
Pharmaco-vigilanceWHO Definition
The science and activities relating to thedetection, assessment, understanding and
prevention of adverse effects or any other drug-related problem
8/9/2019 PV and Glossary.
3/28
Need of PharmacovigilanceAt the time of approval, clinical trial data are available on limited
numbers of patients treated for relatively short periods
Once a product is marketed, large numbers of patients maybe exposed,including:
Patients with co-morbid illnesses
Patients using concomitant medications
Patients with chronic exposure
After marketing, new safety information may become available:
Through use of the product domestically or in other
countries Through use of other drugs in the same class
From preclinical studies,Pharmacological Studies andcontrolled clinical trials
8/9/2019 PV and Glossary.
4/28
How Pharmacovigilance
Spontaneous ReportingIntensive monitoring (hospital)Prescription Event Monitoring
Case Control SurveillanceComprehensive population databases, data-miningPatient seriesObservational studies
8/9/2019 PV and Glossary.
5/28
Definition:Adverse Event vs. Adverse Reaction
Adverse Drug ReactionA noxious and unintended response to a medicine whichoccurs at doses normally used in man for treatment,
prophylaxis, diagnosis or modification of physiologicalfunction .
Adverse Event:untoward medical occurrence which does not necessarilyhave to have a causal relationship with the treatment
Administration of the Drug may result in the developmentof:
Side effect
Untoward effects
Toxic effects
Allergic and idiosyncratic effects
8/9/2019 PV and Glossary.
6/28
Serious Adverse Events
Any untoward medical occurrence that at any dose results in:DeathIs life-threatening
Requires or prolongs patient hospitalisationResults in permanent disability/incapacity or isA congenital anomaly/ birth defectOther medically significant event (e.g. blood dyscrasias,seizures)
Does not include NON-serious events that have thePOTENTIAL to be SERIOUS if allowed to progress further,nor SEVERE events
8/9/2019 PV and Glossary.
7/28
Adverse Drug Reaction vs. Adverse Event
Adverse Drug Reaction(event attributed to drug)
Adverse Event
All Spontaneous
reports
Events not attributed to drug
Diseases
Other Drugs
Environment
Diet
Genetics
Compliance
Otherfactors
8/9/2019 PV and Glossary.
8/28
Definitions
Side effects: Pharmacological effects produced with
therapeutic dose of the drug Side effect which are troublesome in a
particular condition may be useful under other circumstances.
Untoward effects:
Develop with therapeutic dose of a drug but areundesirable If severe may necessitate the cessation of
treatment
8/9/2019 PV and Glossary.
9/28
Definition cont..... Toxic Effects:
With Repeated administration of the drug With large doses Dose dependent
eg. depression of respiration with morphine Hepatotoxicity due to paracetamol.
8/9/2019 PV and Glossary.
10/28
Definition
Unexpected ADR:
Premarketing Drugs - ADR specificity or severity of which is not
consistent with the current investigator's brouchure Risk information described in general
investigational plan or elsewhere in thecurrent application .
Marketed Product
ADR not listed in the current labeling for the drug. Event having greater severity than listed in
labeling eg. hepatic necrosis- if the labeling only referred
to elevated hepatic enzyme
8/9/2019 PV and Glossary.
11/28
Drug Intolerance Drug Intolerance
Quantitative Type A ADR
Qualitative
Type B ADR Idiosyncrasy
Genetic/ Unknown Mechanism Allergic
Immunological
Types I,II,III,IV
8/9/2019 PV and Glossary.
12/28
Quantitative intolerance
Type A : Augmented/Attenuated Predictable Dose related
Hyper-response to the main action of a drug Hypoglycemia due to insulin
Effect due to an action of the drug at another site
Anti-cholinergic effect of phenothiazines.
8/9/2019 PV and Glossary.
13/28
Qualitative Intolerance
Type B: (Bizarre) Unpredicatble Not dose related Mechanism is genetic or immunologic
Idiosyncrasy: genetically determined atypical /bizarre effect
Genetically determined total absence of
reduced activity of enzyme Barbiturate ---> excitement & mental confusion Quinine---->cramps , diarrhoea, purpura,
asthma, vascular collapse
8/9/2019 PV and Glossary.
14/28
Drug Allergy
derived from Greek word: allos- altered and ergos -energy
Immunologically mediated
Independent of dose
Occurs in a small proportion;
Prior sensitization required
1-2 weeks required after first dose
Drug acts as an antigen or Hapten
Chemically related drugs may show cross sensitivity
Same drug can cause diff allergic reactions in diff individuals
8/9/2019 PV and Glossary.
15/28
Immune System
Immune system consist of 2 divisions:
Innate immunity
(NK, macrophages, dendritic cells, neutrophils,
basophils, eosinophils, tissue mast cells, epithelialcells-recognizes & destroy foreign Ag &pathogens without prior exposure
Adaptive immunity
characterized by antigen-specific responses toforeign antigen or pathogens
Takes several days to develop
8/9/2019 PV and Glossary.
16/28
Immunologic Reaction
Type I reaction (IgE-mediated)
Anaphylaxis from Lactam antibiotic Type II reaction (cytotoxic)
Hemolytic anemia from penicillin Type III reaction (immune complex)
Serum sickness from anti-thymocyte globulin Type IV reaction (delayed, cell-mediated)
Contact dermatitis from topic anti-histaminics Specific T-cell activation
Stevens-Johnson Syndrome
8/9/2019 PV and Glossary.
17/28
Other types of ADRPhototoxic : Drug accumulates in skin --- absorbs light
--- photochemical reaction --- photobiologicalreaction --- tissue damage [Eg erythema, edema,blistering etc] Eg tetracyclines
Photoallergic : drug --- cell mediated immuneresponse --- contact dermatitis on exposure to light.Eg sulfonamides, griseofulvin etc.
Drug Dependence : Psychological: (Habituation) &Physical dependence: with withdrawal symptoms
Teratogenicity : Drug use in pregnancy affectsoffspring
8/9/2019 PV and Glossary.
18/28
Adverse Reactions:Possible CausesIntrinsic factors of the drug Pharmacological
Idiosyncratic
Carcinogenicity, Mutagenicity
Teratogenicity
Extrinsic factors Adulterants
Contamination
Underlying medical conditionsInteractionsWrong usage
8/9/2019 PV and Glossary.
19/28
Definition Cont....
Risk in a population of exposed persons; the probability of an eventaffecting members of a particular population (e.g. 1 in 1,000).Absolute risk can be measured over time ( incidence ) or at a giventime (prevalence).
Association
Events associated in time but not necessarily linked as cause andeffect.
Absolute risk
8/9/2019 PV and Glossary.
20/28
Attributable risk Difference between the risk in an exposed population
(absolute risk ) and the risk in an unexposed population(reference risk ). Also referred to as excess risk.
Attributable risk is the result of an absolute comparison between outcome frequency measurements, such as incidence.
Examples : If the exposed persons with a particular outcome are A, the exposed persons without theoutcome are B, the unexposed persons with the outcomeare C and the unexposed persons without the outcome
are D, then the attributable risk is calculated as : [A / (A+B)] - [C / (C+D)].
8/9/2019 PV and Glossary.
21/28
Glossary- Conti....
Benefit
An estimated gain for an individual or a population. See also Effectiveness/Risk.
Benefit - risk analysisExamination of the favourable (beneficial) and unfavourable results
of undertaking a specific course of action. (While this phrase isstill commonly used, the more logical pairings of benefit-harmand effectiveness-risk are slowly replacing it).
C li
8/9/2019 PV and Glossary.
22/28
Causality assessment
The evaluation of the likelihood that a medicine was the causativeagent of an observed adverse reaction. Causality assessment is
usually made according established algorithms.De-challenge
The withdrawal of a drug from a patient; the point at which thecontinuity, reduction or disappearance of adverse effects may be
observed.Effectiveness/risk
The balance between the rate of effectiveness of a medicine versusthe risk of harm is a quantitative assessment of the merit of a
medicine used in routine clinical practice. Comparativeinformation between therapies is most useful. This is moreuseful than the efficacy and hazard predictions from pre-marketing information that is limited and based on selectedsubjects.
8/9/2019 PV and Glossary.
23/28
Definition Cont....Incidence
The extent or rate of occurrence, especially the number of newcases of a disease in a population over a period of time.
Medical error
An unintended act (either of omission or commission) or one thatdoes not achieve its intended outcomes.
Rechallenge
The point at which a drug is again given to a patient after its previous withdrawal
8/9/2019 PV and Glossary.
24/28
8/9/2019 PV and Glossary.
25/28
f
8/9/2019 PV and Glossary.
26/28
Definitions Cont.. Prescription event Monitoring (PEM)
System created to monitor AD events in apopulation.
Prescribers are requested to report all events,regardless of whether they are suspected adverse
events Also known as Cohort event monitoring.
Prescription only Monitoring
Medicinal product available to the public only onprescription
Prophylaxis Prevention or protection
D fi i i C
8/9/2019 PV and Glossary.
27/28
Definition Cont... Signal
Reported information on a possible causalrelationship between as adverse event and adrug
Unknown relationship or incompletelydocumented information
Spontaneous Reporting
System whereby case reports of adverse drugevents are voluntarily submitted from healthprofessionals and pharmaceuticalmanufacturers to the national regulatoryauthority.
8/9/2019 PV and Glossary.
28/28
Thank You
Next lecture: Signal Detection and Causality
Assessment